In India, the drug landscape has changed
dramatically in recent years and already has come to the point of being next to
the nation's IT business in terms of overall volume and revenue. India is one
of the global top six medicine producers.
Vaccines from India are shipped towards more than 150 countries.
Approximately 70% of patients take Indian medicines in developing economies.There are reportedly
10,500 production sites in India and thus more than 3,000 drug companies
growing at an unprecedented speed.Over 90% of products accepted for Anti-malarial,
Antiretroviral & Anti-tubercular have also been approved to India globally.Because
of low deployment and operating costs, total costs of manufacturing in India
are only about 35-40% of the US. India is among the leading global exporters of
generic formulation in terms of quantity.India's drug exports in 2013-14 stood
at the US $15 billion.Indian exports are robust and include different pharmaceuticals divisions from
APIs to contemporary and ancient Indian drug remedies. Indian drug production
makes up approximately one point four percent in value terms of global drug manufacturing
and ten percent in terms of output. India is well-positioned to be among the key
drivers of healthcare delivery for everyone. Thereby reducing the
rather-increasing healthcare expense of industrialized, and developing
countries.
There
is indeed a clamor in the country for highly skilled pharmaceutical
professionals.Numerous pharmacy colleges & institutions mainly deliver
pharmacy graduates to meet the pharmaceutical industry's expectations.There are
indications, nevertheless, that there is still a considerable difference
between the syllabus taught and industry prerequisites.It contributes to a
dramatic drop in employment opportunities for Pharma graduates.
Analogously, the task of hospital pharmacists and
community pharmacist has expanded and is now not just an individual providing
the medication.He is also engaged in educating patients, tracking potential
side effects, documenting detrimental drug outcomes as well as plays a crucial
role in research into drug discovery.
And so it is imperative to redesign the syllabi for
pharmacy courses at all tiers of pharmaceutical education (Diploma, Bachelor, Masters,as
well as Doctoral) to train skilled professionals and to strengthen the national
health care system.In every transition phase of maximizing pharmaceutical
education, consultations are required with all relevant parties, including
govt, academia, industrial sector, scientists, graduates, field researchers,
and so forth.The review process must be time-framed to frame a workable plan on
pharmacy learning.The evaluation framework concepts are:
01. Government reforms for improving the quality of
education
02. A categorization of institutions including
credentials
03. Incorporating knowledge and skills with
curriculum
04. Technology deployment enabled training
05. Attributing pharmacy training towards healthcare
and social concerns
06. Adherence to the business sector so pharmacy
learning is aligned with career prospects
07. To train the instructors to achieve consistency
and quality
08. Instilling professional, and ethical behavior
09. Encouraging innovation and research
10. Subsidizing Pharmacy education
11. Cultivating support structures for pupils
